Cargando…
Study designs, duration, and choice of comparators including the use of placebo
This paper discusses some methodological issues that are relevant to the design of controlled trials of new medicinal products for use in the treatment of schizophrenia. Two issues are covered more generally and at greater length. The first is the use of placebo. Recent debate of this topic was stím...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Les Laboratoires Servier
2002
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181692/ https://www.ncbi.nlm.nih.gov/pubmed/22033562 |